Clinical studies recruiting near Knoxville

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · University of Tennessee - Knoxville · National Cancer Institute (NCI) · NCT05564390 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · East Tennessee Childrens Hospital · National Cancer Institute (NCI) · NCT05099003 EBT Fruit and Vegetable Prescription
NA · Cherokee Health Systems, Dameron Avenue Pedatrics · The University of Tennessee, Knoxville · NCT05028205 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · East Tennessee Childrens Hospital · National Cancer Institute (NCI) · NCT06172296 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · University of Tennessee - Knoxville · NRG Oncology · NCT05624996 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · East Tennessee Childrens Hospital · National Cancer Institute (NCI) · NCT05691478 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Accellacare of Knoxville · Amgen · NCT07037433 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · University of Tennessee Medical Center ( Site 6012) · Merck Sharp & Dohme LLC · NCT07216703 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · University of Tennessee Medical Center · Eli Lilly and Company · NCT06890598 Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Phase 3 · TG Therapeutics Investigational Trial Site · TG Therapeutics, Inc. · NCT05877963 A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Phase N/A · Southeastern Retina Associates, P.C. · Astellas Pharma Global Development, Inc. · NCT06779773 Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
NA · Turkey Creek Medical Center · Innova Vascular, Inc. · NCT06041594 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · East Tennessee Childrens Hospital · Children's Oncology Group · NCT04322318 Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement
NA · Thompson Proton Center · Covenant Health Cancer Center · NCT06200259 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Tennessee Cancer Specialists · Pfizer · NCT07144280 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Thompson Cancer Survival Center ( Site 0097) · Merck Sharp & Dohme LLC · NCT06077760 Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · University of Tennessee - Knoxville · NRG Oncology · NCT06532279 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · Knoxville Kidney Center, PLLC · Biogen · NCT06962800 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Covenant Health Cancer Centers · NRG Oncology · NCT05174169 Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing
NA · Parkwest Medical Center · University of British Columbia · NCT04634240 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Thompson Cancer Survival Center ( Site 0168) · Merck Sharp & Dohme LLC · NCT06623422 A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · University of Tennessee Medical Center · Janssen Research & Development, LLC · NCT06319820 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 3 · Tennessee Cancer Specialists · Takeda · NCT06499285 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · University of Tennessee - Knoxville · Alliance for Clinical Trials in Oncology · NCT06876714 Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi
Phase 3 · Research Site · AstraZeneca · NCT06357533 A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-
Phase 2 · Tennessee Cancer Specialists ( Site 7004) · Merck Sharp & Dohme LLC · NCT06890884 Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Phase 2/Phase 3 · University of Tennessee Medical Center · Exelixis · NCT06943755 A Study to Learn About a Vaccine Against E Coli in Healthy Adults
Phase 1 · Alliance for Multispecialty Research, LLC · Pfizer · NCT07122986 eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (CO
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT07177339 A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H
Phase 2/Phase 3 · PMG Research of Knoxville /ID# 256854 · AbbVie · NCT06345339

Look up another city

Look up another condition